HF Advisory Group LLC Sells 515 Shares of IQVIA Holdings Inc. (NYSE:IQV)

HF Advisory Group LLC decreased its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 6.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,473 shares of the medical research company’s stock after selling 515 shares during the period. HF Advisory Group LLC’s holdings in IQVIA were worth $1,771,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in IQV. Canada Pension Plan Investment Board lifted its stake in shares of IQVIA by 6.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,403,488 shares of the medical research company’s stock valued at $719,634,000 after purchasing an additional 211,653 shares during the last quarter. Lazard Asset Management LLC raised its holdings in IQVIA by 0.9% during the 1st quarter. Lazard Asset Management LLC now owns 3,263,944 shares of the medical research company’s stock valued at $825,416,000 after buying an additional 30,014 shares during the period. Farallon Capital Management LLC lifted its position in IQVIA by 3.1% in the second quarter. Farallon Capital Management LLC now owns 2,923,032 shares of the medical research company’s stock worth $618,046,000 after buying an additional 86,870 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in IQVIA by 3.8% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,510,685 shares of the medical research company’s stock worth $634,927,000 after buying an additional 92,293 shares during the period. Finally, Capital Research Global Investors increased its position in IQVIA by 7.2% during the first quarter. Capital Research Global Investors now owns 2,138,802 shares of the medical research company’s stock valued at $540,882,000 after acquiring an additional 143,533 shares during the last quarter. Hedge funds and other institutional investors own 89.62% of the company’s stock.

Insiders Place Their Bets

In other news, insider Eric Sherbet sold 1,300 shares of IQVIA stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the transaction, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

IQV has been the subject of several analyst reports. Royal Bank of Canada restated an “outperform” rating and issued a $270.00 target price on shares of IQVIA in a report on Friday, November 1st. The Goldman Sachs Group dropped their target price on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Deutsche Bank Aktiengesellschaft cut their target price on IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Barclays dropped their price objective on IQVIA from $260.00 to $255.00 and set an “overweight” rating for the company in a report on Friday, November 1st. Finally, Argus upgraded IQVIA to a “strong-buy” rating in a research note on Wednesday, July 31st. Four investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $259.13.

IQVIA Price Performance

Shares of IQV opened at $212.96 on Wednesday. The stock has a market capitalization of $38.65 billion, a PE ratio of 27.95, a PEG ratio of 2.07 and a beta of 1.51. The company has a 50 day moving average price of $232.84 and a 200-day moving average price of $229.54. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. IQVIA Holdings Inc. has a fifty-two week low of $190.20 and a fifty-two week high of $261.73.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.